Tony Habgood

Tony Habgood is a Senior Scientist in Pharmacology at Exonate Limited, an early-stage biotech company focused on developing novel small molecules for the treatment of vascular diseases. Prior to this, Tony worked as a Research Technician / PhD student at the University of Nottingham, funded by GlaxoSmithKline, where Tony developed in-vivo models of respiratory disease. Tony also has experience as an Integrative Pharmacologist at AstraZeneca and as a Senior Technician at Harlan Laboratories, Inc. Tony holds a PhD in Respiratory Medicine from the University of Nottingham, along with a BSc (Hons) in Pharmacology / Physiology and an FdSc in Biological Sciences from Nottingham Trent University.